BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31431500)

  • 21. Bufalin, a traditional oriental medicine, induces apoptosis in human cancer cells.
    Takai N; Kira N; Ishii T; Yoshida T; Nishida M; Nishida Y; Nasu K; Narahara H
    Asian Pac J Cancer Prev; 2012; 13(1):399-402. PubMed ID: 22502710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Critical role of heat shock protein 27 in bufalin-induced apoptosis in human osteosarcomas: a proteomic-based research.
    Xie XB; Yin JQ; Wen LL; Gao ZH; Zou CY; Wang J; Huang G; Tang QL; Colombo C; He WL; Jia Q; Shen JN
    PLoS One; 2012; 7(10):e47375. PubMed ID: 23091618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of colitis-associated carcinogenesis through modulation of IL-6/STAT3 pathway by balsalazide and VSL#3.
    Do EJ; Hwang SW; Kim SY; Ryu YM; Cho EA; Chung EJ; Park S; Lee HJ; Byeon JS; Ye BD; Yang DH; Park SH; Yang SK; Kim JH; Myung SJ
    J Gastroenterol Hepatol; 2016 Aug; 31(8):1453-61. PubMed ID: 26711554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging.
    Yeh CT; Rao YK; Ye M; Wu WS; Chang TC; Wang LS; Wu CH; Wu AT; Tzeng YM
    Toxicol Appl Pharmacol; 2012 May; 261(1):31-41. PubMed ID: 22465936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
    He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
    Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402/5-FU cells.
    Gu W; Liu L; Fang FF; Huang F; Cheng BB; Li B
    Oncol Rep; 2014 Jan; 31(1):216-22. PubMed ID: 24173654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VEGFR2 Signaling Prevents Colorectal Cancer Cell Senescence to Promote Tumorigenesis in Mice With Colitis.
    Foersch S; Sperka T; Lindner C; Taut A; Rudolph KL; Breier G; Boxberger F; Rau TT; Hartmann A; Stürzl M; Wittkopf N; Haep L; Wirtz S; Neurath MF; Waldner MJ
    Gastroenterology; 2015 Jul; 149(1):177-189.e10. PubMed ID: 25797700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of Colitis and Colitis-Associated Colorectal Cancer by a Novel Polypharmacological Histone Deacetylase Inhibitor.
    Wei TT; Lin YT; Tseng RY; Shun CT; Lin YC; Wu MS; Fang JM; Chen CC
    Clin Cancer Res; 2016 Aug; 22(16):4158-69. PubMed ID: 27528734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bufalin: A Systematic Review of Research Hotspots and Antitumor Mechanisms by Text Mining and Bioinformatics.
    Zhang X; Zhao X; Liu K; Che Y; Qiu X; Qu Y; Sun X; Song J
    Am J Chin Med; 2020; 48(7):1633-1650. PubMed ID: 33148004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of chronic low-dose aspirin treatment on tumor prevention in three mouse models of intestinal tumorigenesis.
    Rohwer N; Kühl AA; Ostermann AI; Hartung NM; Schebb NH; Zopf D; McDonald FM; Weylandt KH
    Cancer Med; 2020 Apr; 9(7):2535-2550. PubMed ID: 31994315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wogonoside prevents colitis-associated colorectal carcinogenesis and colon cancer progression in inflammation-related microenvironment via inhibiting NF-κB activation through PI3K/Akt pathway.
    Sun Y; Zhao Y; Wang X; Zhao L; Li W; Ding Y; Kong L; Guo Q; Lu N
    Oncotarget; 2016 Jun; 7(23):34300-15. PubMed ID: 27102438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-chain fatty acids administration is protective in colitis-associated colorectal cancer development.
    Tian Y; Xu Q; Sun L; Ye Y; Ji G
    J Nutr Biochem; 2018 Jul; 57():103-109. PubMed ID: 29694938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-tumor activities and apoptosis-regulated mechanisms of bufalin on the orthotopic transplantation tumor model of human hepatocellular carcinoma in nude mice.
    Han KQ; Huang G; Gu W; Su YH; Huang XQ; Ling CQ
    World J Gastroenterol; 2007 Jun; 13(24):3374-9. PubMed ID: 17659679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The sodium pump α1 subunit regulates bufalin sensitivity of human glioblastoma cells through the p53 signaling pathway.
    Lan YL; Zou YJ; Lou JC; Xing JS; Wang X; Zou S; Ma BB; Ding Y; Zhang B
    Cell Biol Toxicol; 2019 Dec; 35(6):521-539. PubMed ID: 30739221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bufalin reverses ABCB1-mediated drug resistance in colorectal cancer.
    Yuan ZT; Shi XJ; Yuan YX; Qiu YY; Zou Y; Liu C; Yu H; He X; Xu K; Yin PH
    Oncotarget; 2017 Jul; 8(29):48012-48026. PubMed ID: 28624793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation of bufalin-loaded pluronic polyetherimide nanoparticles, cellular uptake, distribution, and effect on colorectal cancer.
    Hu Q; Liang B; Sun Y; Guo XL; Bao YJ; Xie DH; Zhou M; Duan YR; Yin PH; Peng ZH
    Int J Nanomedicine; 2014; 9():4035-41. PubMed ID: 25187707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bufalin induces apoptosis through activation of both the intrinsic and extrinsic pathways in human bladder cancer cells.
    Hong SH; Choi YH
    Oncol Rep; 2012 Jan; 27(1):114-20. PubMed ID: 21901250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bufalin Induces Apoptosis and Improves the Sensitivity of Human Glioma Stem-Like Cells to Temozolamide.
    Liu J; Zhang Y; Sun S; Zhang G; Jiang K; Sun P; Zhang Y; Yao B; Sui R; Chen Y; Guo X; Tang T; Shi J; Liang H; Piao H
    Oncol Res; 2019 Mar; 27(4):475-486. PubMed ID: 29793559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Research progress of in vitro and in vivo anti-tumor effects and formulation of bufalin].
    Xu Y; Chen M; Jin XF; Qian C; Xu XM; Zhang X
    Zhongguo Zhong Yao Za Zhi; 2014 Aug; 39(15):2829-33. PubMed ID: 25423817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.